Literature DB >> 20130140

Three-dimensional organization of promyelocytic leukemia nuclear bodies.

Marion Lang1, Thibaud Jegou, Inn Chung, Karsten Richter, Sandra Münch, Anikó Udvarhelyi, Christoph Cremer, Peter Hemmerich, Johann Engelhardt, Stefan W Hell, Karsten Rippe.   

Abstract

Promyelocytic leukemia nuclear bodies (PML-NBs) are mobile subnuclear organelles formed by PML and Sp100 protein. They have been reported to have a role in transcription, DNA replication and repair, telomere lengthening, cell cycle control and tumor suppression. We have conducted high-resolution 4Pi fluorescence laser-scanning microscopy studies complemented with correlative electron microscopy and investigations of the accessibility of the PML-NB subcompartment. During interphase PML-NBs adopt a spherical organization characterized by the assembly of PML and Sp100 proteins into patches within a 50- to 100-nm-thick shell. This spherical shell of PML and Sp100 imposes little constraint to the exchange of components between the PML-NB interior and the nucleoplasm. Post-translational SUMO modifications, telomere repeats and heterochromatin protein 1 were found to localize in characteristic patterns with respect to PML and Sp100. From our findings, we derived a model that explains how the three-dimensional organization of PML-NBs serves to concentrate different biological activities while allowing for an efficient exchange of components.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130140     DOI: 10.1242/jcs.053496

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  54 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Combining FISH with localisation microscopy: Super-resolution imaging of nuclear genome nanostructures.

Authors:  Yanina Weiland; Paul Lemmer; Christoph Cremer
Journal:  Chromosome Res       Date:  2011-01       Impact factor: 5.239

Review 3.  Hitchhiking on host chromatin: how papillomaviruses persist.

Authors:  Alison A McBride; Nozomi Sakakibara; Wesley H Stepp; Moon Kyoo Jang
Journal:  Biochim Biophys Acta       Date:  2012-01-28

4.  Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Authors:  Yunyun Geng; Shamci Monajembashi; Anwen Shao; Di Cui; Weiyong He; Zhongzhou Chen; Peter Hemmerich; Jun Tang
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

5.  Morphological, Biochemical, and Functional Study of Viral Replication Compartments Isolated from Adenovirus-Infected Cells.

Authors:  Paloma Hidalgo; Lourdes Anzures; Armando Hernández-Mendoza; Adán Guerrero; Christopher D Wood; Margarita Valdés; Thomas Dobner; Ramón A Gonzalez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

6.  The MORC family: new epigenetic regulators of transcription and DNA damage response.

Authors:  Da-Qiang Li; Sujit S Nair; Rakesh Kumar
Journal:  Epigenetics       Date:  2013-05-17       Impact factor: 4.528

7.  Assembly dynamics of PML nuclear bodies in living cells.

Authors:  Peter Brand; Thorsten Lenser; Peter Hemmerich
Journal:  PMC Biophys       Date:  2010-03-05

Review 8.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

9.  Resolving the spatial relationship between intracellular components by dual color super resolution optical fluctuations imaging (SOFI).

Authors:  Maria Elena Gallina; Jianmin Xu; Thomas Dertinger; Adva Aizer; Yaron Shav-Tal; Shimon Weiss
Journal:  Opt Nanoscopy       Date:  2013-02-25

10.  The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.

Authors:  Pei Xu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.